Two newer groups of medications prescribed for Type 2 diabetes named SGLT2 inhibitors and GLP-1 receptor agonists could reduce risks associated with chronic kidney disease (CKD) and heart disease.
from Medindia Health News https://ift.tt/3kUXIQt
No comments:
Post a Comment